. 2021 Jul 15;11(7):697. doi: 10.3390/life11070697

Table 2.

Factors associated with % AN reduction at week 12.

		% AN Reduction	p
OCP treatment	Yes	53.90 (5.49)	0.049
OCP treatment	No	38.42 (5.49)
Age ^b		−0.48 (0.30)	0.111
Family history ^a	Yes	42.79 (6.50)	0.515
Family history ^a	No	48.14 (4.98)	0.515
Disease duration ^b		−0.64 (0.41)	0.129
BMI ^b		−0.42 (0.54)	0.439
Smoking habit ^a	Yes	46.15 (6.11)	0.999
Smoking habit ^a	No	46.17 (6.11)	0.999
Concomitant therapy ^a	Oral doxycycline	51.83 (4.94)	0.066
Concomitant therapy ^a	Clindamycin gel	36.91 (6.32)	0.066
Hurley stage ^a	I	54.76 (6.34)	0.2647
	II	40.60 (5.61)
	III	44.38 (9.82)
Number of affected areas ^b		3.47 (3.39)	0.310

AN, total abscess and inflammatory nodule count; AN12, AN count reduction at week 12; BMI, Body Mass Index; OCP, oral contraceptive pills. ^a The Student’s t test for independent samples or the ANOVA test was used to evaluate the association between AN count reduction week 12 (AN12) and categoric variables, data are expressed as a mean (standard deviation). ^b Simple linear regression was performed to evaluate the association between AN12 and continuous variables, the data are expressed as a beta coefficient (standard deviation).